Accumulation and activation of natural killer cells in local intraperitoneal HIV-1/MuLV infection results in early control of virus infected cells

Cellular Immunology

Volumn 272, Issue 1, 2011, Pages 71-78

  Johansson, Susanne E ^a,b   Brauner, Hanna ^a   Hinkula, Jorma ^c   Wahren, Britta ^a,b   Berg, Louise ^a   Johansson, Maria H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Acute infection; CD27; HIV 1; Mac 1; Murine leukemia virus; NK cell

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CYTOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MOUSE; MURINE LEUKEMIA VIRUS; NATURAL KILLER CELL; NONHUMAN; PERITONEUM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; VIRUS INFECTION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD27; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; INJECTIONS, INTRAPERITONEAL; KILLER CELLS, NATURAL; LEUKEMIA VIRUS, MURINE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MACROPHAGE-1 ANTIGEN; MACROPHAGES; MICE; MICE, TRANSGENIC; MONOCYTES; REASSORTANT VIRUSES; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS;

EID: 80455160070     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.09.005     Document Type: Article

References (44)

1. Lee S.H., Miyagi T., Biron C.A. Keeping NK cells in highly regulated antiviral warfare. Trends Immunol. 2007, 28:252-259.
2. Orange J.S. Human natural killer cell deficiencies. Curr. Opin. Allergy Clin. Immunol. 2006, 6:399-409.
3. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323-1326.
4. Gazit R., Gruda R., Elboim M., Arnon T.I., Katz G., Achdout H., Hanna J., Qimron U., Landau G., Greenbaum E., Zakay-Rones Z., Porgador A., Mandelboim O. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 2006, 7:517-523.
5. Mandelboim O., Lieberman N., Lev M., Paul L., Arnon T.I., Bushkin Y., Davis D.M., Strominger J.L., Yewdell J.W., Porgador A. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001, 409:1055-1060.
6. Ward J., Bonaparte M., Sacks J., Guterman J., Fogli M., Mavilio D., Barker E. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 2007, 110:1207-1214.
7. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999, 17:189-220.
8. Orange J.S., Wang B., Terhorst C., Biron C.A. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 1995, 182:1045-1056.
9. Loh J., Chu D.T., O'Guin A.K., Yokoyama W.M., Virgin H.W.t. Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J. Virol. 2005, 79:661-667.
10. Sato K., Hida S., Takayanagi H., Yokochi T., Kayagaki N., Takeda K., Yagita H., Okumura K., Tanaka N., Taniguchi T., Ogasawara K. Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta. Eur. J. Immunol. 2001, 31:3138-3146.
11. Scott-Algara D., Truong L.X., Versmisse P., David A., Luong T.T., Nguyen N.V., Theodorou I., Barre-Sinoussi F., Pancino G. Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J. Immunol. 2003, 171:5663-5667.
12. Carrington M., Martin M.P., van Bergen J. KIR-HLA intercourse in HIV disease. Trends Microbiol. 2008, 16:620-627.
13. Alter G., Teigen N., Ahern R., Streeck H., Meier A., Rosenberg E.S., Altfeld M. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J. Infect. Dis. 2007, 195:1452-1460.
14. Alter G., Teigen N., Davis B.T., Addo M.M., Suscovich T.J., Waring M.T., Streeck H., Johnston M.N., Staller K.D., Zaman M.T., Yu X.G., Lichterfeld M., Basgoz N., Rosenberg E.S., Altfeld M. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 2005, 106:3366-3369.
15. Giavedoni L.D., Velasquillo M.C., Parodi L.M., Hubbard G.B., Hodara V.L. Cytokine expression natural killer cell activation and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J. Virol. 2000, 74:1648-1657.
16. Hu P.F., Hultin L.E., Hultin P., Hausner M.A., Hirji K., Jewett A., Bonavida B., Detels R., Giorgi J.V. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995, 10:331-340.
17. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M.A., Marcenaro E., Bottino C., Moretta L., Moretta A., Fauci A.S. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. USA 2003, 100:15011-15016.
18. Boberg A., Brave A., Johansson S., Wahren B., Hinkula J., Rollman E. Murine models for HIV vaccination and challenge. Expert Rev. Vaccines 2008, 7:117-130.
19. Andang M., Hinkula J., Hotchkiss G., Larsson S., Britton S., Wong-Staal F., Wahren B., Ahrlund-Richter L. Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model. Proc. Natl. Acad. Sci. USA 1999, 96:12749-12753.
20. Hinkula J., Rollman E., Lundholm P., Benthin R., Okuda K., Wahren B. Genetic immunization with multiple HIV-1 genes provides protection against HIV-1/MuLV pseudovirus challenge in vivo. Cells Tissues Organs 2004, 177:169-184.
21. Daniels K.A., Devora G., Lai W.C., O'Donnell C.L., Bennett M., Welsh R.M. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 2001, 194:29-44.
22. Prlic M., Gibbs J., Jameson S.C. Characteristics of NK cell migration early after vaccinia infection. J. Immunol. 2005, 175:2152-2157.
23. Reading P.C., Whitney P.G., Pickett D.L., Tate M.D., Brooks A.G. Influenza viruses differ in ability to infect macrophages and to induce a local inflammatory response following intraperitoneal injection of mice. Immunol. Cell Biol. 2010, 88:641-650.
24. Salazar-Mather T.P., Lewis C.A., Biron C.A. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J. Clin. Invest. 2002, 110:321-330.
25. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2001, 2:951-956.
26. Chiossone L., Chaix J., Fuseri N., Roth C., Vivier E., Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009, 113:5488-5496.
27. Hayakawa Y., Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 2006, 176:1517-1524.
28. Brauner H., Elemans M., Lemos S., Broberger C., Holmberg D., Flodstrom-Tullberg M., Karre K., Hoglund P. Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. J. Immunol. 2010, 184:2272-2280.
29. Kim S., Iizuka K., Kang H.S., Dokun A., French A.R., Greco S., Yokoyama W.M. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 2002, 3:523-528.
30. Koo G.C., Dumont F.J., Tutt M., Hackett J., Kumar V. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J. Immunol. 1986, 137:3742-3747.
31. Devito C., Levi M., Broliden K., Hinkula J. Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents. J. Immunol. Methods 2000, 238:69-80.
32. Hinkula J., Rosen J., Sundqvist V.A., Stigbrand T., Wahren B. Epitope mapping of the HIV-1 gag region with monoclonal antibodies. Mol. Immunol. 1990, 27:395-403.
33. Robbins S.H., Tessmer M.S., Mikayama T., Brossay L. Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J. Immunol. 2004, 173:259-266.
34. Martinez J., Huang X., Yang Y. Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J. Immunol. 2008, 180:1592-1597.
35. Ehl S., Nuesch R., Tanaka T., Myasaka M., Hengartner H., Zinkernagel R. A comparison of efficacy and specificity of three NK depleting antibodies. J. Immunol. Methods 1996, 199:149-153.
36. Seaman W.E., Sleisenger M., Eriksson E., Koo G.C. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol. 1987, 138:4539-4544.
37. Choi E.I., Reimann K.A., Letvin N.L. In vivo natural killer cell depletion during primary simian immunodeficiency virus infection in rhesus monkeys. J. Virol. 2008, 82:6758-6761.
38. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., Ghrayeb J., Forman M.A., Montefiori D.C., Rieber E.P., Letvin N.L., Reimann K.A. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283:857-860.
39. Webster R.L., Johnson R.P. Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology 2005, 115:206-214.
40. Glas R., Franksson L., Une C., Eloranta M.L., Ohlen C., Orn A., Karre K. Recruitment activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J. Exp. Med. 2000, 191:129-138.
41. Persson C.M., Chambers B.J. Plasmacytoid dendritic cell-induced migration and activation of NK cells in vivo. Eur. J. Immunol. 2010, 40:2155-2164.
42. Gregoire C., Chasson L., Luci C., Tomasello E., Geissmann F., Vivier E., Walzer T. The trafficking of natural killer cells. Immunol. Rev. 2007, 220:169-182.
43. Makino M., Winkler D.F., Wunderlich J., Hartley J.W., Morse H.C., Holmes K.L. High expression of NK-1.1 antigen is induced by infection with murine AIDS virus. Immunology 1993, 80:319-325.
44. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999, 10:661-671.